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and Colombia and resembles the first cases of CA-MRSA 
described in the early 1990s as occurring in indigenous peo-
ple living in remote areas of Western Australia (4). Second, 
considering that the most predominant CA-MRSA clones in 
Latin America carry SCCmec IV (1,5), finding SCCmec V 
in this isolate was not expected. MRSA carrying SCCmec 
V have been well characterized as colonizers and agents of 
infection in animals and in humans in close contact with an-
imals (mainly in Europe but also in other parts of the world) 
(6). These livestock-associated MRSA clones predominant-
ly belong to ST97 (which are usually not PVL producers) 
and ST398. In addition, ST398 SCCmec V MRSA isolates 
from pigs in Peru have been described (7). Of note, methi-
cillin-susceptible S. aureus t701 and MRSA t701 carrying 
SCCmec II have recently been found in China, isolated 
from patients during food poisoning outbreaks and from 
colonized pork butchers, respectively (8,9). In South Amer-
ica, isolation of non–PVL-producing MRSA t701 (carrying 
SCCmec IVc) and methicillin-sensitive S. aureus t701 from 
colonized inpatients has been well described (10). Although 
speculation that animal carriage might have played a role 
in this infection is tempting, further studies are needed to 
recognize the origin of this MRSA ST6-SCCmec V PVL 
producer in this area of the Amazon Basin. 
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To the Editor: Human contact with wildlife is a lead-
ing cause of disease spillover. Bats, in particular, host 
numerous zoonotic pathogens, from henipaviruses to lys-
saviruses (1). In Ghana, the straw-colored fruit bat (Eido-
lon helvum) frequently and closely interacts with humans 
through roosting in urban areas and human harvesting of 
bushmeat. Large colonies live in Accra, the capital city, 
and >128,000 bats, on average, are hunted for food yearly 
in southern Ghana alone (2). Serologic evidence of human 
infection with novel paramyxoviruses from E. helvum bats 
(3) supports concerns regarding this contact. In addition, 
Kosoy et al. (4) isolated several new strains of Bartonella 
that were found in >30% of E. helvum bats, whereas Billet-
er et al. found Bartonella in 66% of their ectoparasites (5), 
with Bartonella transmissibility to other species unknown. 
This prevalence causes concern because many Bartonella 
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species are zoonotic and cause substantial human disease 
(6). Previous studies of febrile patients in Thailand have 
shown prevalence rates of <25% for antibodies against 
zoonotic Bartonella species (7). Serologic studies have 
been conducted in Europe and in the United States, but few 
studies have examined such prevalence in Africa among 
patients and in the general population (8). 
To address these concerns, we conducted a prevalence 
study in Ghana, West Africa, for evidence of bat-associated 
Bartonella infection in humans and other common animal 
species. We sampled humans who had close contact with 
fruit bats and also sampled domestic animals that lived 
around the bat colonies.
We obtained serum samples from 335 volunteers from 
Accra and the Volta region who had close contact with E. 
helvum bats and also sampled 70 domestic animals that 
lived underneath bat colonies (5 cats, 23 chickens, 7 cows, 
6 dogs, 21 goats, 8 sheep) in Accra. We used 3 testing ap-
proaches: culture, PCR, and indirect immunofluorescent 
assays for serologic testing. We tested serum specimens 
for antibodies against B. henselae, B. quintana, B. clar-
ridgeiae, B. vinsonii vinsonii, B. elizabethae, and Barton-
ella strain E1–105, which had been isolated from E. hel-
vum bats (6).
All culture results for human and domestic animal 
samples were negative for Bartonella species. One human 
serum sample was positive for B. clarridgeiae by PCR, 
which was confirmed by repeat testing. No other human 
samples were consistently positive by PCR. Of 70 animal 
blood clots and 62 serum samples tested by using PCR, 1 
serum sample from a cat tested positive for B. henselae. 
One human serum sample was positive by immunofluo-
rescent assay for antibodies against B. henselae at titers of 
1:128, another had reactivity to B. henselae at 1:64, and 1 
sample was reactive at 1:32. Five human serum samples 
were reactive to B. quintana at titers of 1:32.
The absence of evidence of any human exposure to 
bat-associated Bartonella suggests that the species iso-
lated from E. helvum bats never or rarely infects humans 
in Ghana. If Nycteribiidae bat flies serve as the vector for 
Bartonella transmission between bats as hypothesized, 
then the high host specificity of these vectors (8) could ex-
plain why little infection is spilling over to other species. 
However, no experimental studies have confirmed that bat 
flies are competent vectors of bat-associated Bartonella 
species or that these ectoparasites only bite bats. These 
facts must be confirmed because bat flies are occasion-
ally found on other animals and whether the parasites can 
successfully use these animals as hosts is unknown (9). 
Although further studies are needed to clarify the dynam-
ics of Bartonella species infection in E. helvum bats, as 
well as the species’ zoonotic potential, the current risk of 
spillover of this bat-associated Bartonella species appears 
low in West Africa. This fact may be useful in directing 
limited public health resources.
The seroprevalence to B. henselae in healthy human 
participants in this study was <1%. The low levels of se-
ropositivity to B. henselae and B. quintana are consistent 
with those found in the only other study on Bartonella 
in humans in sub-Saharan Africa: a survey of 155 sub-
jects in the Democratic Republic of Congo showed 1% 
seroprevalence of B. henselae and <1% seroprevalence of 
B. quintana (8).
The results of study in the Democratic Republic of 
Congo and this study contrast with some studies in Asia 
and Europe, which show higher rates of human exposure 
to Bartonella species. For example, a study of febrile pa-
tients in Thailand found serologic evidence of exposure to 
Bartonella infection in 25% of patients (7).
Laudisoit et al. (8) were, to our knowledge, the first 
to report evidence of Bartonella infection in humans in 
Africa. Our study contributes to this nascent effort of un-
derstanding Bartonella on the continent. Because a sub-
stantial proportion of Bartonella prevalence studies have 
been done on hospital patients, our study provides a survey 
of the general population to help determine background 
infection rates and illuminate the complex risks posed by 
this zoonosis.
The research for this article was carried out during  
fieldwork in southern Ghana; at the 37 Military Hospital in 
Accra; at the University of Cambridge, Cambridge, UK; and at 
the Centers for Disease Control and Prevention, Fort Collins, 
Colorado, USA.
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To the Editor: Arthropodborne viruses (arboviruses) 
cause substantial human disease worldwide and have a pro-
nounced effect on public health throughout Asia. Zika virus, 
discovered in Uganda in 1947 (1), is a flavivirus related to 
the following viruses: dengue (DENV), West Nile, Japanese 
encephalitis, and yellow fever. Like DENV, Zika virus is 
transmitted by Aedes mosquitoes. Zika virus emerged as a 
public health problem in 2007, when it caused an epidemic 
in Micronesia (2). Since then, the virus has caused epidem-
ics elsewhere in the Pacific islands (3) and recently emerged 
in South America (4). Zika virus has been reported to cause 
mild and self-limited infection that can be misdiagnosed as 
dengue because of similar clinical features and serologic 
cross-reactivity (2). Zika virus has not, however, been re-
ported to cause substantial thrombocytopenia or result in the 
serious vascular leakage that can be fatal in DENV infection.
Until recently, most evidence for Zika virus infection 
in Asia, including in Indonesia (5), has been serologic, but 
recent virus strains isolated from persons in Thailand (6), 
the Philippines (7), and Cambodia (8) have begun to clarify 
its genomic diversity. Phylogenetically, Zika virus appears 
to have 2 major lineages, African and Asian (9).
During December 2014–April 2015, a confirmed out-
break of dengue (determined by reverse transcription PCR 
[RT-PCR] for DENV and nonstructural protein 1 [NS1] 
antigen detection; data not shown) occurred in Jambi Prov-
ince, central Sumatra, Indonesia. We received samples from 
103 case-patients with clinically diagnosed dengue; these 
samples had been negative for DENV by RT-PCR, NS1 an-
tigen detection, or evidence of seroconversion by ELISA 
(data not shown). We tested the samples for other viruses 
using alphavirus and flavivirus RT-PCR (targeting genome 
positions 6533–6999 and 8993–9258, respectively). In par-
allel, we attempted virus isolation using Vero cells. 
One sample, JMB-185, came from a 27-year-old man 
who sought treatment at the Jambi city hospital 2 days after 
illness onset with a sudden high fever, headache, elbow and 
knee arthralgia, myalgia, and malaise. He did not exhibit 
some common clinical characteristics of Zika virus infec-
tion (10), including maculopapular rash, conjunctivitis, or 
peripheral edema. Hematologic testing revealed lymphocy-
topenia and monocytosis; platelet count was within refer-
ence range. Results of all assays were negative for DENV, 
including NS1 antigen detection with NS1 Ag Rapid Test 
(SD Bioline, Kyong, South Korea); PanBio Dengue Early 
NS1 ELISA (Alere, Brisbane, Australia); PanBio Dengue 
Duo IgM and IgG ELISA (Alere); and Simplexa real-time 
RT-PCR (Focus Diagnostics, Cypress, CA, USA). The ill-
ness was self-limiting, and the patient recovered 2 days af-
ter he sought treatment without any complications.
Of the 103 DENV-negative specimens we tested, only 
JMB-185 was positive for flavivirus and displayed cyto-
pathic effects when cultured in Vero cells for 10 days. A 
subsequent passage was performed, and supernatants from 
both passages were tested for flaviviruses by RT-PCR. A 
265-bp amplicon was generated from JMB-185 by using fla-
vivirus consensus primers. This consensus amplicon prod-
uct had ≈85% nucleotide identity with the prototype Zika 
virus (strain MR 766, 1947, Uganda). An additional larger 
amplicon was generated (nt 9278–9808 of NS5 gene), and 
a phylogenetic tree was constructed based on the partial se-
quence of the NS5 region (530 bp) for JMB-185 (GenBank 
accession no. KU179098) and other Zika virus sequences, 
including those from Cambodia, Yap Island, Thailand, and 
the Philippines (Figure). Phylogenetic analysis indicated 
that JMB-185 belonged to the Zika virus Asian lineage and 
had 99.24% nucleotide identity to an isolate from a Cana-
dian visitor to Thailand (10). It was also close to a Zika 
virus strain isolated from an Australian traveler who had 
visited Java (on the basis of a different NS5 region; data 
not shown). The original serum and passage samples were 
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